- Home
- INLF vs MNOV Comparison
INLF vs MNOV Comparison
Compare INLF & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INLF | MNOV |
|---|---|---|
| Founded | 2016 | 2000 |
| Country | China | United States |
| Employees | 156 | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.6M | 69.4M |
| IPO Year | N/A | 2004 |
Fundamental Metrics
Financial Performance| Metric | INLF | MNOV |
|---|---|---|
| Price | $4.13 | $1.39 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $7.50 |
| AVG Volume (30 Days) | ★ 21.9K | 17.4K |
| Earning Date | 03-06-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,360,807.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $180.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 194.15 |
| 52 Week Low | $0.24 | $1.17 |
| 52 Week High | $5.20 | $1.96 |
Technical Indicators
Market Signals| Indicator | INLF | MNOV |
|---|---|---|
| Relative Strength Index (RSI) | 63.70 | 47.28 |
| Support Level | $0.50 | $1.30 |
| Resistance Level | $4.69 | $1.43 |
| Average True Range (ATR) | 0.38 | 0.03 |
| MACD | -0.05 | -0.00 |
| Stochastic Oscillator | 66.37 | 25.60 |
Price Performance
Historical ComparisonAbout INLF INLIF LIMITED
INLIF Ltd, through its subsidiary, is engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms. In addition, it offers installation and warranty services for manipulator arms, and accessories and raw materials for manipulator arms. Its portfolio includes injection molding machine-dedicated manipulator arms, including transverse single and double-axis manipulator arms, transverse and longitudinal multi-axis manipulator arms, and large bullhead multi-axis manipulator arms.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.